Printer Friendly

SUPERBUG TREATMENT WELCOMED A LIVERPOOL.

A LIVERPOOL student struck down by the potentially-deadly infection clostridium difficile (C diff) today welcomed a breakthrough in its treatment.

Experts say the superbug C diff, characterised by fever and diarrhoea, is a considerable burden on NHS budgets and its high recurrence rate in patients leads to prolonged hospital stays.

Now a company, Astellas Pharma, has developed what it says is the first new treatment for C diff since the 1950s, called DIFICLIR (fidaxomicin).

Liverpool John Moores student Liz Whiteside, 25, from Walton, who was struck by the infection in December, 2010, is along those welcoming it.

She said: "This would've been lifechanging for me. "I would not have needed to re-do a whole year at uni and lost the tuition fee."
COPYRIGHT 2012 MGN Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Liverpool Echo (Liverpool, England)
Date:Jun 26, 2012
Words:122
Previous Article:THUG IS JAILED FOR DRUGS LOSS THREATS; Vulnerable man attacked, court told.
Next Article:RUDDY GLAD TO STAY AT CANARIES.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters